Sign up to save your podcasts
Or
Share How KEYNOTE-189 Transformed Clinical Practice Overnight
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How KEYNOTE-189 Transformed Clinical Practice Overnight
Guest: Howard (Jack) West, MD
Proven to be both statistically and clinically significant, KEYNOTE-189 has offered pivotal outcomes for patients with non-small cell lung cancer (NSCLC). Join Dr. Howard Jack West as he analyzes the substantial influence of this clinical trial.
Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
View all episodes
By ReachMDGuest: Howard (Jack) West, MD
Proven to be both statistically and clinically significant, KEYNOTE-189 has offered pivotal outcomes for patients with non-small cell lung cancer (NSCLC). Join Dr. Howard Jack West as he analyzes the substantial influence of this clinical trial.
Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.